Cited by 1,133Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research

The DOI matches its Crossref record; 250 of the 250 references it cites were found in a registry or an index.

Tau pathology and neurodegeneration

Spillantini, Maria Grazia, Goedert, Michel·2013·The Lancet Neurology

DOI 10.1016/s1474-4422(13)70090-5

Open this paper in CoChat — free account

Abstract

The pathway leading from soluble and monomeric to hyperphosphorylated, insoluble and filamentous tau protein is at the centre of many human neurodegenerative diseases, collectively referred to as tauopathies. Dominantly inherited mutations in MAPT, the gene that encodes tau, cause forms of frontotemporal dementia and parkinsonism, proving that dysfunction of tau is sufficient to cause neurodegeneration and dementia. However, most cases of tauopathy are not inherited in a dominant manner. The first tau aggregates form in a few nerve cells in discrete brain areas. These become self propagating and spread to distant brain regions in a prion-like manner. The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies.

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(13)70090-5

Cites

250 of 250 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Items 201–250 of 250

Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein
Ramachandran, G., & Udgaonkar, J. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.271874 · Cited by 143
Transgenic animal models of tauopathies
Lee, V. M. ‐., Kenyon, T. K., & Trojanowski, J. Q. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.014 · Cited by 141
A role for FKBP52 in tau protein function
Chambraud, B., Sardin, E., Giustiniani, J., Dounane, O., Schumacher, M., Goedert, M., & Baulieu, E.-E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914957107 · Cited by 140
Self-citation
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Van der Jeugd, A., Hochgräfe, K., Ahmed, T., Decker, J. M., Sydow, A., Hofmann, A., Wu, D., Messing, L., Balschun, D., D’Hooge, R., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0987-3 · Cited by 135
“Prion‐Like” Templated Misfolding in Tauopathies
Clavaguera, F., Lavenir, I., Falcon, B., Frank, S., Goedert, M., & Tolnay, M. (2013) · Brain Pathology · doi:10.1111/bpa.12044 · Cited by 133
Self-citation
Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility
Sahara, N., Lewis, J. M., Deture, M. A., McGowan, E. M., Dickson, D. W., Hutton, M., & Yen, S.-H. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01241.x · Cited by 127
Cell-Mediated Neuroprotection in a Mouse Model of Human Tauopathy
Hampton, D. W., Webber, D. J., Bilican, B., Goedert, M., Spillantini, M. G., & Chandran, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0834-10.2010 · Cited by 127
Self-citation
Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease
Hurtado, D. E., Molina-Porcel, L., Carroll, J. C., MacDonald, C., Aboagye, A. K., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0889-12.2012 · Cited by 126
Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease
Schwab, C., Hosokawa, M., & McGeer, P. L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.03.016 · Cited by 126
Analysis of Tau Phosphorylation and Truncation in a Mouse Model of Human Tauopathy
Delobel, P., Lavenir, I., Fraser, G. M., Ingram, E., Holzer, M., Ghetti, B. F., Spillantini, M. G., Crowther, R. A., & Goedert, M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2008.070627 · Cited by 124
Self-citation
Grape Derived Polyphenols Attenuate Tau Neuropathology in a Mouse Model of Alzheimer's Disease
Wang, J., Santa‐María, I., Ho, L., Ksiȩżak-Reding, H., Ono, K., Teplow, D. B., & Pasinetti, G. M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101074 · Cited by 123
The Physiological Link between Metabolic Rate Depression and Tau Phosphorylation in Mammalian Hibernation
Stieler, J., Bullmann, T., Kohl, F., Tøien, Ø., Brückner, M. K., Härtig, W., Barnes, B. M., & Arendt, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014530 · Cited by 123
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
Shiryaev, N., Jouroukhin, Y., Giladi, E., Polyzoidou, E., Grigoriadis, N., Rosenmann, H., & Gozes, I. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.02.011 · Cited by 122
Tau isoform composition influences rate and extent of filament formation
Zhong, Q., Congdon, E. E., Nagaraja, H. N., & Kuret, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.364067 · Cited by 122
Age-appropriate cognition and subtle dopamine-independent motor deficits in aged Tau knockout mice
Morris, M., Hamto, P., Adame, A., Devidze, N., Masliah, E., & Mucke, L. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.003 · Cited by 117
A comparison of degeneration in motor thalamus and cortex between progressive supranuclear palsy and Parkinson's disease
Halliday, G. M., Macdonald, V., & Henderson, J. M. (2005) · Brain · doi:10.1093/brain/awh596 · Cited by 115
Biochemical Staging of Synucleinopathy and Amyloid Deposition in Dementia With Lewy Bodies
Deramecourt, V., Bombois, S., Maurage, C., Ghestem, A., Drobecq, H., Vanmechelen, E., Lebert, F., Pasquier, F., & Delacourte, A. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000205145.54457.ea · Cited by 109
Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Nash, K. R., Lee, D. C., Hunt, J. B., Morganti, J. M., Selenica, M.-L., Moran, P., Reid, P., Brownlow, M., Guang-Yu Yang, C., Savalia, M., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.011 · Cited by 108
Identification of Aminothienopyridazine Inhibitors of Tau Assembly by Quantitative High-Throughput Screening
Crowe, A., Huang, W., Ballatore, C., Johnson, R. L., Hogan, A. L., Huang, R., Wichterman, J., McCoy, J. G., Huryn, D. M., Auld, D. S., et al. (2009) · Biochemistry · doi:10.1021/bi9006435 · Cited by 104
Variations in filament conformation dictate seeding barrier between three- and four-repeat Tau
Dinkel, P. D., Siddiqua, A., Huynh, H., Shah, M., & Margittai, M. (2011) · Biochemistry · doi:10.1021/bi2004685 · Cited by 104
A presenilin 1 mutation in the first case of Alzheimer's disease
Müller, U., Winter, P., & Graeber, M. B. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70307-1 · Cited by 100
Methylene Blue Reduced Abnormal Tau Accumulation in P301L Tau Transgenic Mice
Hosokawa, M., Arai, T., Masuda‐Suzukake, M., Nonaka, T., Yamashita, M., Akiyama, H., & Hasegawa, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052389 · Cited by 95
Tau aggregation into fibrillar polymers: taupathies
Ávila, J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01676-8 · Cited by 94
Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms
Tolnay, M., Sergeant, N., Ghestem, A., Chalbot, S., de Vos, R. A., Jansen Steur, E. N., Probst, A., & Delacourte, A. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0591-z · Cited by 89
The heat shock-induced hyperphosphorylation of τ is estrogen-independent and prevented by androgens: Implications for Alzheimer disease
Papasozomenos, S. C. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6612 · Cited by 89
Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus
Caffrey, T. M., Joachim, C., & Wade-Martins, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.002 · Cited by 88
Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice
Blanchard, J., Wanka, L., Tung, Y.-C., Cárdenas-Aguayo, M. D. C., LaFerla, F. M., Iqbal, K., & Grundke-Iqbal, I. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0734-6 · Cited by 85
Secretion of human tau fragments resembling CSF‐tau in Alzheimer's disease is modulated by the presence of the exon 2 insert
Kim, W., Lee, S., & Hall, G. F. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.042 · Cited by 83
Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
Wischik, C. M., & Staff, R. T. (2009) · The journal of nutrition health & aging · doi:10.1007/s12603-009-0046-5 · Cited by 82
Cellular mechanisms of protein aggregate propagation
Holmes, B. B., & Diamond, M. I. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3ee0 · Cited by 80
Systematic Identification of Tubulin-interacting Fragments of the Microtubule-associated Protein Tau Leads to a Highly Efficient Promoter of Microtubule Assembly
Fauquant, C., Redeker, V., Landrieu, I., Wieruszeski, J., Verdegem, D., Laprévôte, O., Lippens, G. M., Gigant, B., & Knossow, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223545 · Cited by 78
Chapter 21 Neurofibrillary pathology of Alzheimer's disease and other tauopathies
Goedert, M. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64022-4 · Cited by 77
Self-citation
Folate Deficiency Induces In Vitro and Mouse Brain Region-Specific Downregulation of Leucine Carboxyl Methyltransferase-1 and Protein Phosphatase 2A Bα Subunit Expression That Correlate with Enhanced Tau Phosphorylation
Sontag, J., Nunbhakdi‐Craig, V., Montgomery, L. G., Arning, E., Bottiglieri, T., & Sontag, E. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2816-08.2008 · Cited by 77
Handbook of Neurology
Oishi, M. (1997) · WORLD SCIENTIFIC eBooks · doi:10.1142/3384 · Cited by 77
Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease
Coomaraswamy, J., Kilger, E., Wölfing, H., Schäfer, C., Kaeser, S. A., Wegenast‐Braun, B. M., Hefendehl, J. K., Wolburg, H., Mazzella, M. J., Ghiso, J. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001056107 · Cited by 74
Self-citation
Abnormal tau species are produced during Alzheimer's disease neurodegenerating process
Flament, S., & Delacourte, A. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81337-7 · Cited by 66
Reduced Axonal Transport and Increased Excitotoxic Retinal Ganglion Cell Degeneration in Mice Transgenic for Human Mutant P301S Tau
Bull, N. D., Гуиди, А., Goedert, M., Martin, K. R. G., & Spillantini, M. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034724 · Cited by 61
Self-citation
Alois Alzheimer: His Life and Times
Goedert, M., & Ghetti, B. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00056.x · Cited by 60
Self-citation
Cytoskeletal pathology in familial cerebral amyloid angiopathy (British type) with non-neuritic amyloid plaque formation
Révész, T., Holton, J. L., Doshi, B., Anderton, B. H., Scaravilli, F., & Plant, G. T. (1999) · Acta Neuropathologica · doi:10.1007/s004010050970 · Cited by 60
Tauopathy models and human neuropathology: similarities and differences
Frank, S., Clavaguera, F., & Tolnay, M. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0291-9 · Cited by 59
Ether stress‐induced Alzheimer‐like tau phosphorylation in the normal mouse brain
Ikeda, Y., Ishiguro, K., & Fujita, S. C. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.01.064 · Cited by 57
Effects of Alzheimer's amyloid-beta and tau protein on mitochondrial function — role of glucose metabolism and insulin signalling
Rhein, V., & Eckert, A. (2007) · Archives of Physiology and Biochemistry · doi:10.1080/13813450701572288 · Cited by 56
Molecular Cloning and Functional Characterization of Chicken Brain Tau: Isoforms with up to Five Tandem Repeats
Yoshida, H., & Goedert, M. (2002) · Biochemistry · doi:10.1021/bi026464m · Cited by 50
Self-citation
Identification of dihydropyridines that reduce cellular tau levels
Evans, C. G., Jinwal, U. K., Makley, L. N., Dickey, C. A., & Gestwicki, J. E. (2010) · Chemical Communications · doi:10.1039/c0cc02253e · Cited by 47
Neuron-specific recombination by Cre recombinase inserted into the murine tau locus
Muramatsu, K., Hashimoto, Y., Uemura, T., Kunii, M., Harada, R., Sato, T., Morikawa, A., & Harada, A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.03.103 · Cited by 26
Progressive supranuclear palsy (PSP): a quantitative study of the pathological changes in cortical and subcortical regions of eight cases
Armstrong, R. A., Lantos, P. L., & Cairns, N. J. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0796-3 · Cited by 23
Immunoelectron Microscopic and Biochemical Studies of Caspase-Cleaved Tau in a Mouse Model of Tauopathy
Lin, W.-L., Dickson, D. W., & Sahara, N. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31822ac9c9 · Cited by 19
Role for peroxisome proliferator-activated receptor-gamma in Alzheimer's disease.
van Geel (2001) · Open Repository and Bibliography (University of Luxembourg) · doi:10.1002/1531-8249(20010201)49:2 · Cited by 7
Untitled work
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Untitled work
Price (1999) · doi:10.1002/1531-8249(199903)45:3

Research works printed but not linked: 4

Alzheimer, 1907, On a peculiar disease of the cerebral cortex, Allg Z Psychiat, 64, 146
Fischer, 1907, Miliary necroses with geodic proliferations of the neurofibrils, a regular change of the cerebral cortex in senile dementia, Monatsschr Psychiat Neurol, 22, 361
Brion, 1985, Immunological detection of tau protein in the lesions of the neurofibrillary degeneration of Alzheimer's disease, Arch Biol (Bruxelles), 95, 229
Wilson, 1997, Free fatty acids stimulate the polymerization of tau and amyloid beta peptides, Am J Pathol, 150, 2181

Sorted by citations

Ageing as a risk factor for neurodegenerative disease
Hou, Y., Dan, X., Babbar, M., Wei, Y., Hasselbalch, S. G., Croteau, D. L., & Bohr, V. A. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0244-7 · Cited by 3,310
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
Fang, E. F., Hou, Y., Palikaras, K., Adriaanse, B. A., Kerr, J. S., Yang, B., Lautrup, S., Hasan-Olive, M. M., Caponio, D., Dan, X., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0332-9 · Cited by 1,740
Pathology of Neurodegenerative Diseases
Dugger, B. N., & Dickson, D. W. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028035 · Cited by 1,665
Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets
Gao, C., Jiang, J., Tan, Y., & Chen, S. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01588-0 · Cited by 1,616
The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans
Holth, J. K., Fritschi, S. K., Wang, C., Pedersen, N. P., Cirrito, J. R., Mahan, T. E., Finn, M. B., Manis, M., Geerling, J. C., Fuller, P. M., et al. (2019) · Science · doi:10.1126/science.aav2546 · Cited by 813

See all 1,133

Authors: Spillantini, M. G., & Goedert, M.
Affiliations: University of Cambridge (GB)
MRC Laboratory of Molecular Biology (GB)
ORCID: Spillantini, Maria Grazia
Goedert, Michel
Venue: The Lancet Neurology
Publisher: Elsevier BV
Published: 2013-06
Volume: 12
Issue: 6
Pages: 609-622
ISSN: 1474-4422 (ISSN-L)
DOI: 10.1016/s1474-4422(13)70090-5
OpenAlex: W2137140827
Cited by: 1,133
References: 250
Citations by year: 2026: 60 · 2025: 89 · 2024: 69 · 2023: 78 · 2022: 97 · 2021: 102 · 2020: 99 · 2019: 113 · 2018: 87 · 2017: 89 · 2016: 80 · 2015: 88 · 2014: 60 · 2013: 19
FWCI: 9.07
Type: journal article
Language: en
Open access: closed
Locations: The Lancet Neurology (publishedVersion)
PubMed (publishedVersion)
Funders: Parkinson's UK (K-1012)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
Keywords: tau pathology, tauopathy, neurodegeneration, tau aggregation, hyperphosphorylated tau, MAPT mutations, frontotemporal dementia, parkinsonism, prion-like propagation, tau-targeted therapy
MeSH terms: Animals, Brain, Humans, tau Proteins, Neurodegenerative Diseases, Tauopathies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Tau pathology and neurodegeneration

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks